PhageDPO: A machine-learning based computational framework for identifying phage depolymerases

被引:0
作者
Vieira, M. Fernanda [1 ]
Duarte, José [1 ]
Domingues, Rita [1 ]
Oliveira, Hugo [1 ,2 ]
Dias, Oscar [1 ,2 ]
机构
[1] Center of Biological Engineering, University of Minho, Braga
[2] LABBELS –Associate Laboratory, Braga/Guimarães
关键词
Bacteriophages; Depolymerases; Machine learning;
D O I
10.1016/j.compbiomed.2025.109836
中图分类号
学科分类号
摘要
Bacteriophages (phages) are the most predominant and genetically diverse biological entities on Earth. Phages are viruses that infect bacteria and encode numerous proteins with potential biotechnological application. However, most phage-encoded proteins remain functionally uncharacterized. Depolymerases (DPOs) in particular, enzymes that degrade external polysaccharide structures, have garnered increasing interest from both fundamental research standpoint and for biotechnological applications to control bacterial pathogens. Despite the proliferation of identification tools for predicting DPOs in phage genomes, we introduced PhageDPO as a robust and reliable solution. PhageDPO is trained on a comprehensive dataset that includes sequences related to seven specific DPO-related domains, completed with DPOs validated in the literature. Training a Support Vector Machine (SVM) model resulted in a test accuracy of 96 %, a recall of 97 %, a precision of 94 % and a F1-score of 96 %, demonstrating its capability in predicting DPOs in phage genomes. The model was further validated using both cases reported in the literature and newly generated data for this study, enhancing its performance. Beyond its predictive performance, PhageDPO distinguishes itself by offering a user-friendly interface coupled with robust performance, making it more accessible and effective compared to other tools with graphical interfaces. © 2025 The Authors
引用
收藏
相关论文
共 52 条
[1]  
Naghavi M., Et al., Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050, Lancet, (2024)
[2]  
Ventola C.L., The antibiotic resistance crisis: Part 1: causes and threats, Pharmacy and Therapeutics, 40, 4, (2015)
[3]  
Romero-Calle D., Benevides R.G., Goes-Neto A., Billington C., Bacteriophages as alternatives to antibiotics in clinical care, Antibiotics, 8, 3, (2019)
[4]  
Duckworth D.H., Gulig P.A., Bacteriophages, BioDrugs, 16, 1, pp. 57-62, (2002)
[5]  
Hatfull G.F., Dark matter of the biosphere: the amazing world of bacteriophage diversity, J. Virol., 89, 16, (2015)
[6]  
Santos S.B., Melo L.D.R., Oliveira H., Phage structural antimicrobial proteins, Bacterial Viruses: Exploitation for Biocontrol and Therapeutics, (2020)
[7]  
Pires D.P., Oliveira H., Melo L.D.R., Sillankorva S., Azeredo J., Bacteriophage-encoded depolymerases: their diversity and biotechnological applications, Appl. Microbiol. Biotechnol., 100, 5, pp. 2141-2151, (2016)
[8]  
Knirel Y.A., Et al., Mechanisms of acinetobacter baumannii capsular polysaccharide cleavage by phage depolymerases, Biochemistry (Mosc), 85, 5, pp. 567-574, (2020)
[9]  
Olszak T., Et al., The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence, Sci. Rep., 7, 1, pp. 1-14, (2017)
[10]  
Oliveira H., Et al., K2 capsule depolymerase is highly stable, is refractory to resistance, and protects larvae and mice from acinetobacter baumannii sepsis, Appl. Environ. Microbiol., 85, 17, pp. 1-12, (2019)